Loading...
Loading...
India accounts for a significant share of global Magnesium exports, with 669+ registered manufacturers shipping to buyers across 149+ countries — yet a handful of companies dominate the shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest share at 27.3% (export value: $98.5M). Close behind, CIPLA LIMITED (15.1%, $54.5M). STRIDES PHARMA SCIENCE LIMITED (2.2%, $7.8M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
Comprehensive supplier network intelligence dashboard
Flow of Magnesium from leading Indian exporters to their key global customers
Top Suppliers → Customer Networks
The Magnesium export market from India is led by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone commands a 27.3% share, shipping $98.5M worth of product across 1.5K shipments. The second-largest exporter, CIPLA LIMITED, contributes $54.5M (15.1%) to the overall market. Combined, the top two suppliers alone account for 42.4% of all Magnesium exports, indicating a relatively concentrated supply base.
Across all 669 tracked manufacturers, the total Magnesium export value stands at $361.3M from 8.4K shipments. The market average shipment value is $42.9K. The single largest buyer relationship in terms of trade value is SUN PHARMA CANADA INC., receiving $54.5M worth of product.
The combined buyer network spans 17 named purchasing companies, including SUN PHARMA CANADA INC., YUSEN LOGISTICS BENELUX, M/S. SUN PHARMA ANZ PTY LTD, SUN PHARMA ANZ PTY LTD, EUROFARMA LABORAT?RIOS S/A and 12 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Magnesium exporter from India, with a market share of 27.3% and a total export value of $98.5M across 1.5K shipments. Their average shipment value of $67.5K is above the market average of $42.9K, suggesting premium or bulk contract pricing.
SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. SUN PHARMA CANADA INC. is the dominant customer, accounting for 55.4% of this supplier's tracked business. Top customers include:
• SUN PHARMA CANADA INC. — $54.5M across 808 shipments (55.4% of this supplier's total exports)
• YUSEN LOGISTICS BENELUX — $18.5M across 274 shipments (18.8% of this supplier's total exports)
• M/S. SUN PHARMA ANZ PTY LTD — $14.8M across 219 shipments (15.0% of this supplier's total exports)
• SUN PHARMA ANZ PTY LTD — $5.8M across 86 shipments (5.9% of this supplier's total exports)
• EUROFARMA LABORAT?RIOS S/A — $5.0M across 73 shipments (5.0% of this supplier's total exports)
Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $67.5K is 57% above the market average of $42.9K, consistent with large-order contracts or value-added formulations.
Once Magnesium leaves the manufacturing plants of companies like SUN PHARMACEUTICAL INDUSTRIES LIMITED and CIPLA LIMITED, it travels to 5 destination markets with a combined import value of $361.3M. United States absorbs the largest share at 36.5% ($131.7M), followed by Belgium (19.9%) and Canada (16.2%).
In United States — the top destination — named importers include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, BIOCON PHARMA INC. In Belgium, key buyers are YUSEN LOGISTICS BENELUX BELGIUM, YUSEN LOGISTICS BENELUX.
This geographic spread reflects Magnesium's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
Comprehensive geographic market intelligence dashboard
Trade flow of Magnesium exports from India — top destination countries and the named companies importing it
Top Countries → Global Importers
United States ranks as the first-largest destination for Magnesium imports from India, with a total trade value of $131.7M across 608 shipments — representing a 36.5% share of all Magnesium exports. The average shipment value of $216.6K is above the global average of $42.9K, indicating high-value procurement contracts or branded formulations. This market is served by 9 tracked buyers.
Named Magnesium importers in United States: CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer, accounting for 35.9% ($47.3M) of this market's total imports.
• CIPLA USA INC UPS SUPPLY CHAIN SOLU — $47.3M (35.9% of United States's total)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $10.0M (7.6% of United States's total)
• BIOCON PHARMA INC — $7.6M (5.8% of United States's total)
Key Insight: United States's per-shipment average of $216.6K (404% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Magnesium imports from India.
Visual overview of India's magnesium supply chain network — top suppliers, destinations, pricing, and trade routes
This video covers India's magnesium pharmaceutical supply chain network — $361.3M in total trade, 149 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.
Latest developments and market context
Detailed market intelligence for Magnesium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify manufacturer licensing and export certifications with the official agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
CIPLA LIMITED is the second-largest Magnesium exporter from India, with a market share of 15.1% and a total export value of $54.5M across 440 shipments. Their average shipment value of $124.0K is above the market average of $42.9K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 77.8% of this supplier's tracked business. Top customers include:
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $42.4M across 342 shipments (77.8% of this supplier's total exports)
• CIPLA USA INC UPS SUPPLY CHAIN SOL — $10.0M across 81 shipments (18.3% of this supplier's total exports)
• BREATHEFREE LANKA PV — $898.4K across 7 shipments (1.6% of this supplier's total exports)
• CIPLA MALAYSIA SDN B — $663.6K across 5 shipments (1.2% of this supplier's total exports)
• SHENZHEN BEIMEI PHAR — $541.5K across 4 shipments (1.0% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $124.0K is 189% above the market average of $42.9K, consistent with large-order contracts or value-added formulations.
STRIDES PHARMA SCIENCE LIMITED is the third-largest Magnesium exporter from India, with a market share of 2.2% and a total export value of $7.8M across 100 shipments. Their average shipment value of $78.4K is above the market average of $42.9K, suggesting premium or bulk contract pricing.
STRIDES PHARMA SCIENCE LIMITED serves 3 named buyers in our database. STRIDES PHARMA INC is the dominant customer, accounting for 71.8% of this supplier's tracked business. Top customers include:
• STRIDES PHARMA INC — $5.6M across 72 shipments (71.8% of this supplier's total exports)
• STRIDES PHARMA INC — $2.2M across 28 shipments (27.6% of this supplier's total exports)
• STRIDES PHARMA INC — $41.9K across 1 shipments (0.5% of this supplier's total exports)
Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $78.4K is 82% above the market average of $42.9K, consistent with large-order contracts or value-added formulations.
ANNORA PHARMA PRIVATE LIMITED is the fourth-largest Magnesium exporter from India, with a market share of 2.0% and a total export value of $7.3M across 197 shipments. Their average shipment value of $37.0K is below the market average of $42.9K, reflecting a high-volume, competitive pricing strategy.
ANNORA PHARMA PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• TO THE ORDER OF. — $3.4M across 91 shipments (46.3% of this supplier's total exports)
• TO THE ORDER OF. — $2.3M across 63 shipments (32.0% of this supplier's total exports)
• TO THE ORDER — $677.9K across 18 shipments (9.3% of this supplier's total exports)
• NA — $458.3K across 12 shipments (6.3% of this supplier's total exports)
• CAMBER PHARMACEUTICA — $448.3K across 12 shipments (6.1% of this supplier's total exports)
Key Insight: ANNORA PHARMA PRIVATE LIMITED operates with high shipment frequency (197 shipments) at a per-shipment value of $37.0K, indicating a broad distribution network with many smaller, regular orders.
BIOCON PHARMA LIMITED is the fifth-largest Magnesium exporter from India, with a market share of 1.9% and a total export value of $6.7M across 188 shipments. Their average shipment value of $35.8K is below the market average of $42.9K, reflecting a high-volume, competitive pricing strategy.
BIOCON PHARMA LIMITED serves 4 named buyers in our database. BIOCON PHARMA INC is the dominant customer, accounting for 77.0% of this supplier's tracked business. Top customers include:
• BIOCON PHARMA INC — $5.2M across 145 shipments (77.0% of this supplier's total exports)
• PRIORITY HEALTHCARE — $995.9K across 28 shipments (14.8% of this supplier's total exports)
• PRIORITY HEALTHCARE — $402.0K across 11 shipments (6.0% of this supplier's total exports)
• BIOCON PHARMA INC — $154.2K across 4 shipments (2.3% of this supplier's total exports)
Key Insight: BIOCON PHARMA LIMITED operates with high shipment frequency (188 shipments) at a per-shipment value of $35.8K, indicating a broad distribution network with many smaller, regular orders.
DR.REDDY'S LABORATORIES LTD is the fifth-largest Magnesium exporter from India, with a market share of 1.1% and a total export value of $3.9M across 228 shipments. Their average shipment value of $17.0K is below the market average of $42.9K, reflecting a high-volume, competitive pricing strategy.
DR.REDDY'S LABORATORIES LTD serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• DR. REDDYS LABORATORIES, INC — $1.2M across 71 shipments (31.2% of this supplier's total exports)
• NORTHSTAR DISTRIBUTI — $1.0M across 60 shipments (26.2% of this supplier's total exports)
• REED-LANE INC 359 NE — $563.0K across 33 shipments (14.5% of this supplier's total exports)
• REED - LANE INC — $555.0K across 33 shipments (14.3% of this supplier's total exports)
• REED - LANE INC — $535.7K across 31 shipments (13.8% of this supplier's total exports)
Key Insight: DR.REDDY'S LABORATORIES LTD operates with high shipment frequency (228 shipments) at a per-shipment value of $17.0K, indicating a broad distribution network with many smaller, regular orders.
Belgium ranks as the second-largest destination for Magnesium imports from India, with a total trade value of $72.0M across 610 shipments — representing a 19.9% share of all Magnesium exports. The average shipment value of $118.0K is above the global average of $42.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Magnesium importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 88.1% ($63.5M) of this market's total imports.
• YUSEN LOGISTICS BENELUX BELGIUM — $63.5M (88.1% of Belgium's total)
• YUSEN LOGISTICS BENELUX — $8.3M (11.5% of Belgium's total)
Key Insight: Belgium's per-shipment average of $118.0K (175% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Belgium is a key market for Magnesium imports from India.
Canada ranks as the third-largest destination for Magnesium imports from India, with a total trade value of $58.6M across 29 shipments — representing a 16.2% share of all Magnesium exports. The average shipment value of $2.0M is above the global average of $42.9K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Magnesium importers in Canada: SUN PHARMA CANADA INC. is the largest buyer, accounting for 93.0% ($54.5M) of this market's total imports.
• SUN PHARMA CANADA INC. — $54.5M (93.0% of Canada's total)
Key Insight: Canada's per-shipment average of $2.0M (4607% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Magnesium imports from India.
Australia ranks as the fourth-largest destination for Magnesium imports from India, with a total trade value of $28.9M across 338 shipments — representing a 8.0% share of all Magnesium exports. The average shipment value of $85.5K is above the global average of $42.9K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.
Named Magnesium importers in Australia: M/S. SUN PHARMA ANZ PTY LTD is the largest buyer, accounting for 57.2% ($16.5M) of this market's total imports.
• M/S. SUN PHARMA ANZ PTY LTD — $16.5M (57.2% of Australia's total)
• SUN PHARMA ANZ PTY LTD. — $7.9M (27.2% of Australia's total)
• SUN PHARMA ANZ PTY LTD — $2.9M (10.0% of Australia's total)
Key Insight: Australia's per-shipment average of $85.5K (99% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Australia is a key market for Magnesium imports from India.
Brazil ranks as the fifth-largest destination for Magnesium imports from India, with a total trade value of $19.7M across 98 shipments — representing a 5.4% share of all Magnesium exports. The average shipment value of $200.8K is above the global average of $42.9K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.
Named Magnesium importers in Brazil: EUROFARMA LABORAT?RIOS S/A is the largest buyer, accounting for 25.2% ($5.0M) of this market's total imports.
• EUROFARMA LABORAT?RIOS S/A — $5.0M (25.2% of Brazil's total)
• RANBAXY FARMACEUTICA LTDA : — $2.7M (13.7% of Brazil's total)
Key Insight: Brazil's per-shipment average of $200.8K (368% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Brazil is a key market for Magnesium imports from India.
Top supplier: 5 customers
6 suppliers → 149 countries
Network value: $361.3M
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
8,413 Verified Shipments
669 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists